{"organizations": [], "uuid": "034595f6bffa66ad201d555de8fcf1b6e139dc82", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-aetna-says-co-cvs-received-request/brief-aetna-says-co-cvs-received-request-for-additional-information-from-the-doj-idUSFWN1PR188", "country": "US", "domain_rank": 408, "title": "BRIEF-Aetna Says Co, CVS Received Request For Additional Information From The DOJ", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-02T00:15:00.000+02:00", "replies_count": 0, "uuid": "034595f6bffa66ad201d555de8fcf1b6e139dc82"}, "author": "", "url": "https://www.reuters.com/article/brief-aetna-says-co-cvs-received-request/brief-aetna-says-co-cvs-received-request-for-additional-information-from-the-doj-idUSFWN1PR188", "ord_in_thread": 0, "title": "BRIEF-Aetna Says Co, CVS Received Request For Additional Information From The DOJ", "locations": [], "entities": {"persons": [], "locations": [{"name": "co", "sentiment": "none"}], "organizations": [{"name": "cvs", "sentiment": "negative"}, {"name": "brief-aetna says co", "sentiment": "negative"}, {"name": "doj", "sentiment": "negative"}, {"name": "doj reuters staff  feb", "sentiment": "none"}, {"name": "aetna inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "aetna inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 1 (Reuters) - Aetna Inc:\n* AETNA INC - ON FEB 1, CO,CVS RECEIVED REQUEST FOR ADDITIONAL INFORMATION FROM THE DOJ\n* AETNA INC - DOJ‘S REQUEST FOR ADDITIONAL INFORMATION IN CONNECTION WITH THE DOJ’S REVIEW OF TRANSACTIONS CONTEMPLATED BY CO‘S MERGER WITH CVS HEALTH\n* AETNA INC - ‍CONTINUES TO PROJECT PROPOSED TRANSACTION WILL BE COMPLETED IN SECOND HALF OF 2018​ Source text - bit.ly/2rYvf61 Further company coverage:\n ", "external_links": [], "published": "2018-02-02T00:15:00.000+02:00", "crawled": "2018-02-02T00:37:49.000+02:00", "highlightTitle": ""}